Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[A case report. FDG-PET in occult breast cancer].
Ladjevardi S, Sörensen J, Hellman P, Juhlin C, Wärnberg F. Ladjevardi S, et al. Among authors: warnberg f. Lakartidningen. 2002 Feb 7;99(6):524-6. Lakartidningen. 2002. PMID: 11881227 Swedish. No abstract available.
The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies.
Karakatsanis A, Christiansen PM, Fischer L, Hedin C, Pistioli L, Sund M, Rasmussen NR, Jørnsgård H, Tegnelius D, Eriksson S, Daskalakis K, Wärnberg F, Markopoulos CJ, Bergkvist L. Karakatsanis A, et al. Among authors: warnberg f. Breast Cancer Res Treat. 2016 Jun;157(2):281-294. doi: 10.1007/s10549-016-3809-9. Epub 2016 Apr 27. Breast Cancer Res Treat. 2016. PMID: 27117158 Free PMC article. Clinical Trial.
Delayed Sentinel Lymph Node Dissection in Patients with a Preoperative Diagnosis of Ductal Cancer In Situ by Preoperative Injection with Superparamagnetic Iron Oxide (SPIO) Nanoparticles: The SentiNot Study.
Karakatsanis A, Eriksson S, Pistiolis L, Olofsson Bagge R, Nagy G, Man V, Kwong A, Wärnberg F; SentiNot Trialists Group. Karakatsanis A, et al. Among authors: warnberg f. Ann Surg Oncol. 2023 Jul;30(7):4064-4072. doi: 10.1245/s10434-022-13064-0. Epub 2023 Jan 31. Ann Surg Oncol. 2023. PMID: 36719570 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 37071240
Magnetic Sentinel Lymph Node Biopsy in Early Breast Cancer Patients: An Individual Patient Data Meta-analysis of Tracer Uptake.
Christenhusz A, Mirzaei N, Karakatsanis A, Eriksson S, Wärnberg F, Olofsson Bagge R, van der Palen J, Simanowski J, Salamzadeh S, Ten Haken B, Dassen AE, Alic L. Christenhusz A, et al. Among authors: warnberg f. Ann Surg Oncol. 2024 Dec 17. doi: 10.1245/s10434-024-16626-6. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39690385
Impact of general anaesthesia on breast cancer survival: a 5-year follow up of a pragmatic, randomised, controlled trial, the CAN-study, comparing propofol and sevoflurane.
Enlund M, Berglund A, Enlund A, Lundberg J, Wärnberg F, Wang DX, Ekman A, Ahlstrand R, Flisberg P, Hedlund L, Östlund I, Bergkvist L; CAN-study group. Enlund M, et al. Among authors: warnberg f. EClinicalMedicine. 2023 Jun 9;60:102037. doi: 10.1016/j.eclinm.2023.102037. eCollection 2023 Jun. EClinicalMedicine. 2023. PMID: 37333664 Free PMC article.
128 results